Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: COMPASS Pathways plc

Market Cap 1.63B 1.41B 1.3B 1.22B 2.28B 155B 2.31B 15.38B 5.98B 75.41B 6.12B 5.99B 261B P/E Ratio 2026 *
-11.8x
P/E Ratio 2027 * -8.48x
Enterprise Value 1.21B 1.04B 961M 900M 1.69B 115B 1.71B 11.38B 4.42B 55.79B 4.53B 4.43B 193B EV / Sales 2026 *
-
EV / Sales 2027 * 18.9x
Free-Float
25.07%
Yield 2026 *
-
Yield 2027 * -
1 day+0.12%
1 week-7.43%
Current month-7.50%
1 month+25.18%
3 months+75.33%
6 months+74.06%
Current year+75.07%
1 week 10.72
Extreme 10.724
12.39
1 month 9.61
Extreme 9.61
14.76
Current year 4.88
Extreme 4.88
14.76
1 year 2.25
Extreme 2.25
14.76
3 years 2.25
Extreme 2.25
14.76
5 years 2.25
Extreme 2.25
49.52
10 years 2.25
Extreme 2.25
61.69
Manager TitleAgeSince
Chief Executive Officer 61 2022-07-31
Director of Finance/CFO 54 2024-02-29
Chief Tech/Sci/R&D Officer 66 2024-04-30
Director TitleAgeSince
Chairman 74 2024-03-28
Director/Board Member 69 2020-03-31
Director/Board Member 66 2021-02-28
Date Insider Type Main position Quantity % Market Cap.
05-26Free

Chairman

30,158 0.0314%
05-26Free

Director

21,110 0.0220%
05-26Free

Director

21,110 0.0220%
Change 5-day change 1-year change 3-year change Capi.($)
+5.87%-7.43%+163.18%+54.08% 1.54B
-0.35%-0.22%-15.03%-12.88% 42.96B
+3.11%-1.17%+277.22%+502.47% 31.73B
+0.22%-2.90%+14.25%-12.16% 30.22B
+1.62%-5.52%+0.79%+22.42% 28.94B
+4.09%-1.98%+11.99%+17.37% 23.87B
-1.63%+1.89%+54.59%+124.83% 13.57B
-0.40%-1.48%+7.48%+7.12% 12.96B
+1.14%-0.36% - - 13.39B
-0.74%-2.47%+102.47%+80.26% 12.2B
Average +0.44%-1.94%+68.55%+87.06% 21.14B
Weighted average by Cap. +0.60%-1.17%+56.72%+95.63%

Financials

2026 *2027 *
Net sales - 60.17M 52.02M 47.92M 44.89M 84.17M 5.72B 85.44M 568M 221M 2.78B 226M 221M 9.64B
Net income -100M -86.74M -79.91M -74.84M -140M -9.54B -142M -947M -368M -4.64B -377M -369M -16.07B -198M -171M -158M -148M -277M -18.86B -282M -1.87B -727M -9.17B -744M -728M -31.76B
Net Debt -424M -367M -338M -316M -593M -40.33B -602M -4B -1.55B -19.62B -1.59B -1.56B -67.94B -493M -426M -393M -368M -690M -46.9B -700M -4.65B -1.81B -22.81B -1.85B -1.81B -78.99B
Logo COMPASS Pathways plc
Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in treating mental health conditions focused on rapid and durable responses through the development of its investigational COMP360 psilocybin treatment. COMP360 is its psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. It commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. It also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.
Employees
156
Date Price Change Volume
26-06-12 12.08 $ +5.87% 2,509,934
26-06-11 11.41 $ +3.45% 3,696,919
26-06-10 11.03 $ -2.04% 2,159,942
26-06-09 11.26 $ -4.01% 3,545,338
26-06-08 11.73 $ -3.14% 3,102,345
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
11.41USD
Average target price
22.20USD
Spread / Average Target
+94.57%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CMPS Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!